AstraZeneca to invest 90 million dollars in India over next 5 years Ruby Khatun Khatun19 April 2018 10:00 AM ISTNew Delhi: Biopharmaceutical firm AstraZeneca said it will invest USD 90 million (around Rs 590 crore) in India over the next five years.The...
Sanofi in talks to sell generics arm to Advent for 2.4 billion dollar Ruby Khatun Khatun19 April 2018 9:45 AM ISTPARIS: French healthcare group Sanofi is in exclusive talks to sell its Zentiva European generics drugs arm to private equity firm Advent...
Boston Scientific acquires nVision Medical Corp Ruby Khatun Khatun19 April 2018 9:30 AM ISTBoston Scientific announced that it has acquired nVision Medical Corporation, a privately-held company focused on women's health.nVision developed the...
Doctors, medical professionals highest paid in India: Report Ruby Khatun Khatun18 April 2018 5:05 PM ISTNew Delhi: Bangalore is the highest paying city in the country, while pharma and healthcare is the highest paying industry for talent in India, a...
USFDA conducts inspection at Cipla's Indore facility Ruby Khatun Khatun18 April 2018 10:45 AM ISTNew Delhi: Drug major Cipla said the US health regulator has conducted an audit at its Indore facility and has not issued any data integrity or repeat...
ICICI Lombard frontrunner for Star Health Ruby Khatun Khatun18 April 2018 10:15 AM ISTMumbai: In a race to acquire Star Health, ICICI Lombard General Insurance Co has emerged as the leader edging past the competing consortium of West...
Another Suitor in Line for Fortis, this time a Chinese Conglomerate Ruby Khatun Khatun18 April 2018 10:05 AM ISTFortis Healthcare Ltd said Fosun International Ltd has offered to invest up to $350 million, making the Chinese conglomerate the fourth suitor aiming...
Indian-American doctors want lowering of cost of prescription drugs Ruby Khatun Khatun18 April 2018 10:00 AM ISTWashington: An influential group of India-American physicians has aligned itself with President Donald Trump's agenda to lower the cost of...
Shire sells cancer drugs to Servier for 2.4 billion dollar as Takeda circles Ruby Khatun Khatun18 April 2018 9:45 AM ISTLONDON: Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical, is selling its...
Survival data boosts Merck's Keytruda lead in lung cancer Ruby Khatun Khatun18 April 2018 9:30 AM ISTNEW YORK/CHICAGO: Merck & Co’s immunotherapy Keytruda plus chemotherapy significantly improved overall survival in newly-diagnosed patients with...
Maximum 24 percent Margin on Scheduled drugs, 30 on Non scheduled: NITI Aayog Ruby Khatun Khatun17 April 2018 5:44 PM ISTNew Delhi: NITI Aayog has recommended a cap on trade margins charged by drug stockiest and chemist in order to reduce the prices of drugs while...
IHH says Fortis board declines to engage on takeover offer Ruby Khatun Khatun17 April 2018 10:30 AM ISTMumbai: Malaysia’s IHH Healthcare Bhd said on Monday India’s Fortis Healthcare Ltd declined to engage with the company regarding a takeover offer,...
